ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
Mid-term clinical and radiographic outcomes at minimum five-year follow-up after stemless reverse shoulder arthroplasty.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStemless reverse total shoulder arthroplasty (rTSA) was developed to preserve humeral bone stock and facilitate revision surgery. While short-term outcomes are promising, mid-term data beyond five years remain limited. The purpose of this study was to evaluate clinical and radiographic outcomes at a minimum follow-up of five years after implantation of a stemless reverse shoulder prosthesis. We hypothesized that metaphyseal fixation would demonstrate sustained clinical function and stable radiographic integration at mid-term follow-up.
methodsThis retrospective case series included 44 consecutive patients who underwent stemless rTSA. At minimum five-year follow-up, 35 patients were available for clinical and radiographic evaluation (follow-up rate 79.5%). Clinical assessment included the Constant Score (CS), age-adjusted Constant Score, American Shoulder and Elbow Surgeons (ASES) score, Simple Shoulder Test (SST), and Visual Analog Scale (VAS) for pain. Radiographic evaluation was performed using standardized two-plane radiographs and assessed for humeral and glenoid radiolucency, implant subsidence, loosening, and scapular notching.
resultsAt a median follow-up of 69 months, patients demonstrated sustained functional outcomes with a median Constant Score of 74 (IQR 71-78), ASES score of 85 (IQR 80-95), SST score of 9.1 ± 2.0, and VAS pain score of 1 (IQR 0-2). The absolute Constant Score decreased slightly between the two- and five-year follow-up; however, this difference was not statistically significant (p = 0.264). Incomplete humeral radiolucent lines < 1 mm were observed in 3 patients (10.7%) and glenoid radiolucent lines in 2 patients (7.1%). No progressive loosening or implant migration was detected.
conclusionStemless reverse shoulder arthroplasty demonstrated favorable clinical outcomes and stable radiographic metaphyseal fixation at a minimum follow-up of five years. No progressive radiographic changes or implant-related complications were observed beyond the initial two postoperative years. While these findings support the mid-term performance of this implant concept, further studies with larger patient cohorts are warranted to confirm these results. LEVEL OF EVIDENCE: IV.
Indexed as
Identifiers
42570130What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.